Nanomaterials continue to gain in popularity in technological, biomedical, and many other applications, but their defining small size may pose…
Articles by Maureen Newman
Promedior, Inc. presented at the American Society of Hematology (ASH) meeting positive results from Stage 1 of its adaptive…
MediciNova, Inc.’s idiopathic pulmonary fibrosis (IPF) drug candidate MN-001 (tipelukast) was recently granted orphan drug status by the US Food…
An influx of research at the University of Colorado, Denver (UCD) concerning the use of Parion Science’s mucolytic agents…
Although multi walled carbon nanotubes (CNTs) are all the rage in product development, finding applications in sporting goods, electronic…
This month, Boehringer Ingelheim presented data concerning the use of nintedanib in patients with idiopathic pulmonary fibrosis (IPF) at…
Representatives from Boehringer Ingelheim will be presenting 18 abstracts containing data from idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease…